Paclitaxel induced B7-H1 expression in cancer cells via the MAPK pathway

Journal of Chemotherapy

Volumn 23, Issue 5, 2011, Pages 295-299

  Gong, Wenrong ^a   Song, Qibin ^b   Lu, Xiaoming ^c   Gong, Wensheng ^d   Zhao, Jianhua ^d   Min, Peng ^b   Yi, Xianjin ^e  

^a HUBEI UNIVERSITY OF ARTS AND SCIENCE   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d XiangFan Center for Disease Control and Prevention   (China)

^e Department of internal Medicine   (United States)

Author keywords

B7 H1; HepG2; Paclitaxel; SW480

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PACLITAXEL; PROGRAMMED DEATH 1 LIGAND 1; ANTINEOPLASTIC AGENT; CD274 PROTEIN, HUMAN; PROTEIN KINASE INHIBITOR; TUMOR PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL STRAIN HEPG2; COLORECTAL CARCINOMA; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UPREGULATION; ADENOCARCINOMA; COLORECTAL TUMOR; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; METABOLISM; PATHOLOGY; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIME; TUMOR CELL LINE;

ADENOCARCINOMA; ANTIGENS, CD274; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MAP KINASE SIGNALING SYSTEM; NEOPLASM PROTEINS; PACLITAXEL; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; UP-REGULATION;

EID: 84866529268     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/joc.2011.23.5.295     Document Type: Article

References (33)

1. Blank C, Kuball J, Voelkl S, Wiendl H, Becker B, Walter B et al. Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro. Int J Cancer 2006;119(2):317-327.
2. Hirano F, Kaneko K, Tamura H, Dong H, Wang S, ichikawa M et al. Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. Cancer Res 2005;65(3):1089-1096.
3. Dong H, Chen L. B7-H1 pathway and its role in the evasion of tumor immunity. J Molecular Med (Berlin, Germany) 2003;81(5):281-287.
4. Dong H, Zhu G, Tamada K, Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nature Med 1999;5(12):1365-1369.
5. Zou W, Chen L. Inhibitory B7-family molecules in the tumour microenvironment. Nature Rev 2008;8(6):467-477.
6. Lukens JR, Cruise MW, Lassen MG, Hahn YS. Blockade of PD-1/B7- H1 interaction restores effector CD8+ T cell responses in a hepatitis C virus core murine model. J immunol 2008;180(7):4875-4884.
7. Curiel TJ, Wei S, Dong H, Alvarez X, Cheng P, Mottram P et al. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nature MEd 2003;9(5):562-567.
8. Dong H, Strome SE, salomao DR, Tamura H, Hirano F, Flies DB et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nature Med 2002;8(8):793-800.
9. Mazanet MM, Hughes CC. B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J immunol 2002;169(7):3581-3588.
10. Schreiner B, Mitsdoerffer M, Kieseier BC, Chen L, Hartung HP, Weller M et al. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. J neuroimmunol 2004;155(1-2):172-182.
11. Muhlbauer M, Fleck M, schutz C, Weiss T, Froh M, Blank C et al. PDL1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosis. J Hepatol 2006;45(4):520-528.
12. Thompson RH, Kuntz SM, Leibovich BC, Dong H, Lohse CM, Webster WS et al. Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. Cancer Res 2006;66(7):3381-3385.
13. Ghebeh H, Mohammed S, Al-Omair A, Qattan A, Lehe C, Al-Qudaihi G et al. The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors. Neoplasia (new York, nY 2006;8(3):190-198.
14. Iwai Y, ishida M, Tanaka Y, Okazaki T, Honjo T, Minato N. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc natl Acad sci USA 2002;99(19):12293-12297.
15. Zhang P, su DM, Liang M, Fu J. Chemopreventive agents induce programmed death-1-ligand 1 (PD-L1) surface expression in breast cancer cells and promote PD-L1-mediated T cell apoptosis. Molec immunol 2008;45(5):1470-1476.
16. Ghebeh H, Lehe C, Barhoush E, Al-Romaih K, Tulbah A, Al-Alwan M et al. Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule. Breast Cancer Res;12(4):R48.
17. Crane CA, Panner A, Murray JC, Wilson SP, Xu H, Chen L et al. Pi(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer. Oncogene 2009;28(2):306-312.
18. Karakhanova S, Meisel S, Ring S, Mahnke K, Enk AH. ERK/p38 MAP-kinases and Pi3K are involved in the differential regulation of B7-H1 expression in DC subsets. Eur J immunol 2009;40(1):254-266.
19. Xu R, Sato N, Yanai K, Akiyoshi T, Nagai S, Wada J et al. Enhancement of paclitaxel-induced apoptosis by inhibition of mitogen-activated protein kinase pathway in colon cancer cells. Anticancer Res 2009;29(1):261-270.
20. Yamamoto R, nishikori M, Tashima M, sakai T, ichinohe T, Takaori-Kondo A et al. B7-H1 expression is regulated by MEK/ERK signaling pathway in anaplastic large cell lymphoma and Hodgkin lymphoma. Cancer sci 2009;100(11):2093-2100.
21. Isomura I, shintani Y, Yasuda Y, Tsujimura K, Morita A. Induction of regulatory dendritic cells by topical application of nF-kappaB decoy oligodeoxynucleotides. Immunol Lett 2008;119(1-2):49-56.
22. Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y, Pignon JP et al. Benefit of adjuvant chemotherapy for resectable gastric cancer: a metaanalysis. JAMA;303(17):1729-1737.
23. Zindl CL, Chaplin DD. Immunology. Tumor immune evasion. Science 2010;328(5979):697-698.
24. Zozulya AL, Ortler S, Fabry Z, Sandor M, Wiendl H. The level of B7 homologue 1 expression on brain DC is decisive for CD8 Treg cell recruitment into the Cns during EAE. Eur J immunol 2009;39(6):1536-1543.
25. Waisman A, Yogev N. B7-H1 and CD8+ Treg: the enigmatic role of B7-H1 in peripheral tolerance. Eur J immunol 2009;39(6):1448-1451.
26. Archibald DJ, Neff BA, Voss SG, Splinter PL, Driscoll CL, Link MJ et al. B7-H1 expression in vestibular schwannomas. Otol neurotol;31(6):991-997.
27. Wang L, Ma Q, Chen X, Guo K, Li J, Zhang M. Clinical significance of b7-h1 and b7-1 expressions in pancreatic carcinoma. World J surg;34(5):1059-1065.
28. Wei J, Barr J, Kong LY, Wang Y, Wu A, Sharma AK et al. Gliomaassociated cancer-initiating cells induce immunosuppression. Clin Cancer Res;16(2):461-473.
29. Ye Y, Zhou L, Xie X, Jiang G, Xie H, Zheng S. Interaction of B7-H1 on intrahepatic cholangiocarcinoma cells with PD-1 on tumor-infiltrating T cells as a mechanism of immune evasion. J surg Oncol 2009;100(6):500-504.
30. Strome SE, Dong H, Tamura H, Voss SG, Flies DB, Tamada K et al. B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma. Cancer Res 2003;63(19):6501-6505.
31. Nomi T, Ssho M, Akahori T, Hamada K, Kubo A, Kanehiro H et al. Clinical significance and therapeutic potential of the programmed death-1 ligand/ programmed death-1 pathway in human pancreatic cancer. Clin Cancer Res 2007;13(7):2151-2157.
32. Nakanishi J, Wada Y, Matsumoto K, Azuma M, Kikuchi K, Ueda S. Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers. Cancer immunol immunother 2007;56(8):1173-1182.
33. Azuma T, Yao S, Zhu G, Flies AS, Flies SJ, Chen L. B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells. Blood 2008;111(7):3635-3643.